Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARTELO BIOSCIENCES, INC.ARTL · Entity 8413 | Director | July 17, 2026 | July 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARTELO BIOSCIENCES, INC.
Report date July 17, 2026 · Filed July 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.15 · Expires 2036-07-17 | Direct | 136 |
Reported balance
After 2026-07-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-17 · Grant · Acquired 136 · Balance 136 F1: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean July 17, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean July 17, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 17, 2026 Filed Jul 21, 2026 22:28 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Option (right to buy) · Derivative | 136 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001640334-26-001227 · form4.xml · derivative · entry 1 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136 Underlying: Common Stock · 136 shares Expires 2036-07-17 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean July 17, 2026. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 21:41 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Options (right to buy) · Derivative | 292 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001640334-26-000194 · form4.xml · derivative · entry 1 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292 Underlying: Common Stock · 292 shares Expires 2036-01-30 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean January 30, 2026. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:01 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001640334-24-001931 · form4.xml · derivative · entry 1 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2034-12-20 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean December 20, 2024. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:08 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Option (right to buy) · Derivative | 1,083 | Not disclosed Strike: $1.55 | Not disclosed |
DisclosureSEC source: 0001640334-24-000331 · primary_doc.xml · derivative · entry 10 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,083 Underlying: Common Stock · 1,083 shares Expires 2033-08-04 F3 · price: The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer). F8 · derivative.exercise_date: Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month). "Amendment Date" shall mean February 28, 2024. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:08 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Option (right to buy) · Derivative | 667 | Not disclosed Strike: $1.55 | Not disclosed |
DisclosureSEC source: 0001640334-24-000331 · primary_doc.xml · derivative · entry 9 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 667 Underlying: Common Stock · 667 shares Expires 2033-06-30 F3 · price: The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer). F8 · derivative.exercise_date: Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month). "Amendment Date" shall mean February 28, 2024. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:08 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Option (right to buy) · Derivative | 667 | Not disclosed Strike: $1.55 | Not disclosed |
DisclosureSEC source: 0001640334-24-000331 · primary_doc.xml · derivative · entry 8 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 667 Underlying: Common Stock · 667 shares Expires 2032-06-24 F3 · price: The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer). F8 · derivative.exercise_date: Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month). "Amendment Date" shall mean February 28, 2024. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:08 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Option (right to buy) · Derivative | 667 | Not disclosed Strike: $1.55 | Not disclosed |
DisclosureSEC source: 0001640334-24-000331 · primary_doc.xml · derivative · entry 7 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 667 Underlying: Common Stock · 667 shares Expires 2031-07-16 F3 · price: The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer). F8 · derivative.exercise_date: Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month). "Amendment Date" shall mean February 28, 2024. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:08 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Option (right to buy) · Derivative | 8,000 | Not disclosed Strike: $1.55 | Not disclosed |
DisclosureSEC source: 0001640334-24-000331 · primary_doc.xml · derivative · entry 6 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2030-12-04 F3 · price: The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer). F8 · derivative.exercise_date: Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month). "Amendment Date" shall mean February 28, 2024. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:08 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | Disposition to issuerStock Option (right to buy) · Derivative | 1,083 | Not disclosed Strike: $2.01 | Not disclosed |
DisclosureSEC source: 0001640334-24-000331 · primary_doc.xml · derivative · entry 5 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,083 shares Expires 2033-08-04 F3 · price: The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer). F7 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean August 4, 2023. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:08 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | Disposition to issuerStock Option (right to buy) · Derivative | 667 | Not disclosed Strike: $1.99 | Not disclosed |
DisclosureSEC source: 0001640334-24-000331 · primary_doc.xml · derivative · entry 4 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 667 shares Expires 2033-06-30 F3 · price: The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer). F6 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 30, 2023. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:08 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | Disposition to issuerStock Option (right to buy) · Derivative | 667 | Not disclosed Strike: $4.89 | Not disclosed |
DisclosureSEC source: 0001640334-24-000331 · primary_doc.xml · derivative · entry 3 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 667 shares Expires 2032-06-24 F5 · derivative.exercise_price: This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022. F3 · price: The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer). F5 · derivative.underlying_shares: This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:08 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | Disposition to issuerStock Option (right to buy) · Derivative | 667 | Not disclosed Strike: $15.00 | Not disclosed |
DisclosureSEC source: 0001640334-24-000331 · primary_doc.xml · derivative · entry 2 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 667 shares Expires 2031-07-16 F4 · derivative.exercise_price: This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022. F3 · price: The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer). F4 · derivative.underlying_shares: This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:08 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | Disposition to issuerStock Option (right to buy) · Derivative | 8,000 | Not disclosed Strike: $9.05 | Not disclosed |
DisclosureSEC source: 0001640334-24-000331 · primary_doc.xml · derivative · entry 1 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2030-12-04 F1 · derivative.exercise_price: This option was granted on December 4, 2020 and was previously reported as covering 120,000 shares at an exercise price of $0.6035 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022. F3 · price: The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer). F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan (the "Plan")) through such applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean December 4, 2020. F1 · derivative.underlying_shares: This option was granted on December 4, 2020 and was previously reported as covering 120,000 shares at an exercise price of $0.6035 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022. Read SEC document |
| August 04, 2023 Filed Aug 8, 2023 20:56 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Option (right to buy) · Derivative | 1,083 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001640334-23-001488 · form4.xml · derivative · entry 1 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,083 Underlying: Common Stock · 1,083 shares Expires 2033-08-04 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean August 4, 2023. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 18:06 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Option (right to buy) · Derivative | 667 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001640334-23-001202 · form4.xml · derivative · entry 1 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 667 Underlying: Common Stock · 667 shares Expires 2033-06-30 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 30, 2023. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 21:17 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001640334-22-001355 · form4.xml · derivative · entry 1 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-06-24 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 24, 2022. Read SEC document |
| July 16, 2021 Filed Jul 26, 2021 20:29 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001640334-21-001685 · form4.xml · derivative · entry 1 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-07-16 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean July 16, 2021. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 23:48 UTC | ARTELO BIOSCIENCES, INC. ARTL · Entity 8413 | GrantStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001640334-20-003022 · form4.xml · derivative · entry 1 Reyes Gregory · CIK 0001404055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2030-12-04 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through such applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean December 4, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.